Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check6 days agoChange DetectedThe page history shows Revision: v3.4.3 added and Revision: v3.4.2 removed. This appears to be a minor site version update rather than changes to the study data or records.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices about government funding lapse and related operating-status details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1. The previous revision reference v3.4.0 was removed.SummaryDifference0.5%

- Check48 days agoChange DetectedThe history page adds a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a new revision label (v3.4.0). Minor wording updates (e.g., No FEAR Act data) and metadata changes are present; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check62 days agoChange DetectedThe history shows a new revision entry (v3.3.4) replacing the previous v3.3.3, with no changes to study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now displays a new footer revision notice 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the previous 'Revision: v3.3.2' text were removed.SummaryDifference0.1%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.